Last reviewed · How we verify
NCT07060703: KTSOS
Clinical and Paraclinical Characterization of Osseous Anomalies of the Long Bones of Patients With Klippel Trénaunay Syndrome
NA trial testing Osteodensitometry in Radiological Bone Phenotype Description of Patients With KTS ( Klippel-Trénaunay Syndrome ) in 15 participants. Participants enrolled and being followed up; not accepting new ones.
15 September 2024
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 12 September 2024 |
| Primary completion | 15 September 2024 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Osteodensitometry
Conditions studied
- Radiological Bone Phenotype Description of Patients With KTS ( Klippel-Trénaunay Syndrome ) — all drugs for Radiological Bone Phenotype Description of Patients With KTS ( Klippel-Trénaunay Syndrome ) →
Sponsor
University Hospital, Grenoble
Who can join
7 and older, any sex, with Radiological Bone Phenotype Description of Patients With KTS ( Klippel-Trénaunay Syndrome ). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical and paraclinical characterization of osseous anomalies of the long bones of patients with Klippel Trénaunay syndrome
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07060703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Osteodensitometry
Trials testing the same drug.
- NCT06476587 — Idiopathic Bilateral Vestibulopathy: Peripheral Vestibular Disorders and Their Repercussions · completed
- NCT03751839 — Microarchitecture, Bone Strength and Fracture Risk in Long-term Type 1 Diabetes · NA · completed
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07060703 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 11 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07060703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing